Sign inGet started

DEMAREE JOHN

Insider CIK 1744959 · KPTI Chief Commercial Officer · GTHX Chief Commercial Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
KPTI Karyopharm Therapeutics In A Award deriv2021-02-252021-03-0143,177— $043,177SEC↗
KPTI Karyopharm Therapeutics In A Award2021-02-252021-03-0115,849— $023,995SEC↗
KPTI Karyopharm Therapeutics In P Buy2020-08-262020-08-277,500$14.54 $109.0K7,500SEC↗
KPTI Karyopharm Therapeutics In A Award deriv2020-03-162020-03-17151,200— $0151,200SEC↗
GTHX G1 Therapeutics, Inc. A Award deriv2020-02-062020-02-0730,000— $030,000SEC↗
GTHX G1 Therapeutics, Inc. A Award deriv2019-01-022019-01-0260,000— $060,000SEC↗
GTHX G1 Therapeutics, Inc. P Buy2018-12-102018-12-111,000$33.15 $33.1K5,250SEC↗
GTHX G1 Therapeutics, Inc. A Award deriv2018-07-032018-07-06225,000— $0225,000SEC↗